Mammen P. Mammen

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

Pablo Tebas, ShuPing Yang, Jean Boyer et al. · EClinicalMedicine · 2020 · 276 citations · Full text

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

Kimberly A. Kraynyak, Elliott Blackwood, Joseph Agnes et al. · The Journal of Infectious Diseases · 2022 · 59 citations · Full text

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes et al. · npj Vaccines · 2021 · 48 citations · Full text

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

Mammen P. Mammen, Pablo Tebas, Joseph Agnes et al. · 2021 · 43 citations · Full text

Abstract Background Vaccines, Immunodeficiencies, Immunology +18

INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes et al. · 2021 · 19 citations · Full text

Vaccination, Immune Evasion, Vaccine Development +15